239 related articles for article (PubMed ID: 17505039)
1. Serum angiopoietin-2 as a clinical marker for lung cancer.
Park JH; Park KJ; Kim YS; Sheen SS; Lee KS; Lee HN; Oh YJ; Hwang SC
Chest; 2007 Jul; 132(1):200-6. PubMed ID: 17505039
[TBL] [Abstract][Full Text] [Related]
2. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer.
Park JH; Choi H; Kim YB; Kim YS; Sheen SS; Choi JH; Lee HL; Lee KS; Chung WY; Lee S; Park KJ; Hwang SC; Lee KB; Park KJ
Lung Cancer; 2009 Dec; 66(3):359-64. PubMed ID: 19339077
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Adv Exp Med Biol; 2013; 788():341-8. PubMed ID: 23835996
[TBL] [Abstract][Full Text] [Related]
4. Serum cripto-1 as a clinical marker for lung cancer.
Xu CH; Cao L; Wei Y; Yu LK
Int J Biol Markers; 2015 Nov; 30(4):e369-73. PubMed ID: 26109366
[TBL] [Abstract][Full Text] [Related]
5. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.
Fawzy A; Gaafar R; Kasem F; Ali SS; Elshafei M; Eldeib M
J Egypt Natl Canc Inst; 2012 Mar; 24(1):41-5. PubMed ID: 23587231
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
[TBL] [Abstract][Full Text] [Related]
7. Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.
Coelho AL; Araújo AM; Gomes MP; Catarino RJ; Andrade EB; Lopes AM; Medeiros RM
Future Oncol; 2015; 11(24):3233-42. PubMed ID: 26562248
[TBL] [Abstract][Full Text] [Related]
8. Serum endothelial monocyte-activating polypeptide-II: a novel biomarker in patients with non-small-cell lung cancer.
Sen E; Ulger F; Kaya A; Akar N; Gonullu U
Clin Lung Cancer; 2008 May; 9(3):166-70. PubMed ID: 18621627
[TBL] [Abstract][Full Text] [Related]
9. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
Takigawa N; Segawa Y; Fujimoto N; Hotta K; Eguchi K
Anticancer Res; 1998; 18(2B):1251-4. PubMed ID: 9615796
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients.
Seker MM; Sancaktar E; Acibucu DO; Filiz AK; Deveci K; Bahceci A; Kacan T; Babacan N; Yuce S
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2929-32. PubMed ID: 24254563
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer.
Liu SG; Yuan SH; Wu HY; Liu J; Huang CS
Cell Biochem Biophys; 2015 May; 72(1):165-9. PubMed ID: 25548002
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
Hu Y; Hu MM; Shi GL; Han Y; Li BL
Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.
Naumnik W; Chyczewska E; Ossolinska M
Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656
[TBL] [Abstract][Full Text] [Related]
18. Serological investigation of the clinical significance of fascin in non-small-cell lung cancer.
Teng Y; Xu S; Yue W; Ma L; Zhang L; Zhao X; Guo Y; Zhang C; Gu M; Wang Y
Lung Cancer; 2013 Nov; 82(2):346-52. PubMed ID: 24070574
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 levels correlate with poor prognosis and vascular endothelial growth factor concentration in the serum of patients with non-small cell lung cancer.
Pan B; Che D; Cao J; Shen J; Jin S; Zhou Y; Liu F; Gu K; Man Y; Shang L; Yu Y
Biomarkers; 2015; 20(4):232-9. PubMed ID: 26301881
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation to relationship between serum vascular endothelial growth factor (VEGF) level, metastases and other tumor markers in patients with lung cancer].
Sağlam DA; Ursavaş A; Karadağ M; Yilmaztepe Oral A; Coşkun F; Gözü RO
Tuberk Toraks; 2008; 56(1):50-5. PubMed ID: 18330755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
